FLOLIPID SIMVASTATIN Trademark

Trademark Overview


On Friday, July 21, 2017, a trademark application was filed for FLOLIPID SIMVASTATIN with the United States Patent and Trademark Office. The USPTO has given the FLOLIPID SIMVASTATIN trademark a serial number of 87537113. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, November 1, 2024. This trademark is owned by Salerno Pharmaceuticals LP. The FLOLIPID SIMVASTATIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, prescription statin medication containing simvastatin for the treatment of coronary heart disease, elevated triglycerides, and LDL cholesterol; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquids, drops, sachets, and pharmaceutical preparations containing simvastatin for the treatment of coronary heart disease, elevated triglycerides and LDL-cholesterol
flolipid simvastatin

General Information


Serial Number87537113
Word MarkFLOLIPID SIMVASTATIN
Filing DateFriday, July 21, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, November 1, 2024
Registration Number5450168
Registration DateTuesday, April 17, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 19, 2017

Trademark Statements


Description of MarkThe mark consists of the stylized wording "FLOLIPID" with the stylized wording "FLO" in a lighter shade and the wording "LIPID" in a darker shade with the smaller stylized wording "SIMVASTATIN" in a darker shade underneath the wording "LIPID"; a highly stylized depiction of a rising sun in a darker shade over a highly stylized shape resembling flowing water in a lighter shade above the wording "FLOLIPID".
Goods and ServicesPharmaceutical preparations, namely, prescription statin medication containing simvastatin for the treatment of coronary heart disease, elevated triglycerides, and LDL cholesterol; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquids, drops, sachets, and pharmaceutical preparations containing simvastatin for the treatment of coronary heart disease, elevated triglycerides and LDL-cholesterol
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"SIMVASTATIN"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, November 1, 2024
Primary Code005
First Use Anywhere DateWednesday, November 15, 2017
First Use In Commerce DateWednesday, November 15, 2017

Trademark Owner History


Party NameSalerno Pharmaceuticals LP
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressBrooksville, FL 34604

Party NameSalerno Pharmaceuticals LP
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressBrooksville, FL 34604

Party NameSalerno Pharmaceuticals LP
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressBrooksville, FL 34604

Trademark Events


Event DateEvent Description
Friday, July 28, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 26, 2017EXAMINER'S AMENDMENT ENTERED
Sunday, November 12, 2017ASSIGNED TO LIE
Tuesday, July 25, 2017NEW APPLICATION ENTERED
Thursday, July 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 23, 2017ASSIGNED TO EXAMINER
Thursday, October 26, 2017EXAMINERS AMENDMENT -WRITTEN
Thursday, October 26, 2017EXAMINERS AMENDMENT E-MAILED
Thursday, October 26, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 1, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, February 23, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, March 13, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 14, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, March 15, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, April 17, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, November 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 19, 2017PUBLISHED FOR OPPOSITION
Tuesday, February 13, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, February 23, 2018USE AMENDMENT FILED
Tuesday, March 13, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, September 6, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, September 11, 2019REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Tuesday, March 31, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 31, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 31, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 31, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 31, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 31, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 2, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Monday, April 17, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, November 1, 2024CANCELLED SEC. 8 (6-YR)